Enhanced Recovery After Surgery (ERAS) in Coronary Artery Bypass Graft / Off Pump Coronary Artery Bypass (CABG/OPCAB)

Brief Summary

It has been assumed that some elements of the ERAS protocol may contribute to the reduction of complications and improve the satisfaction of patients undergoing coronary artery bypass surgery. Elements of the ERAS strategy will be tested in this study. The elements that prove to be feasible and have a positive effect on the treatment process will be introduced into everyday clinical practice. In the next stage of the research, we are planning to investigate whether the introduction of the ERAS strategy has had a long-term positive effect on the quality of life after treatment (a survey 1 month and 6 months after leaving the hospital).

Intervention / Treatment

  • Premedication visit (BEHAVIORAL)
    detailed information about surgery, anaesthesia and postoperative period
  • Preoperative period (DRUG)
    administration of melatonin 5 mg in the evening and pregabalin 75 mg one hour before entering the operating theatre
  • Postoperative period (OTHER)
    Fluids 1 ml/kg/h; Discontinuation of propofol at the moment of drainage and cardiovascular system stabilization; Fluids administered orally 2 hours after extubation; Early mobilisation
  • Intraoperative period (DRUG)
    Continuous infusion of balanced multi-electrolyte fluids 1-3 ml/kg/h

Condition or Disease

  • Coronary Artery Disease
  • Coronary Stenosis

Phase

Study Design

Study type: OBSERVATIONAL
Status: Unknown status
Study results: No Results Available
Age: Child, Adult, Older Adult
Enrollment: 100 (ACTUAL)
Funded by: Other
Time Perspective: Prospective
Observational Model: Case-Control

Masking

Clinical Trial Dates

Start date: May 03, 2019 ACTUAL
Primary Completion: Jan 01, 2020 ESTIMATED
Completion Date: May 01, 2021 ESTIMATED
Study First Posted: May 20, 2019 ACTUAL
Results First Posted: Aug 31, 2020
Last Updated: May 17, 2019

Sponsors / Collaborators

Responsible Party: N/A

Evaluation of the impact of implemented elements of the ERAS strategy on the results of surgical treatment of coronary artery disease in the aspect of:

* preoperative preparation (comprehensive information, premedication, hydration),
* haemodynamic stability (discontinuation of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers immediately before surgery), optimal pre- and intraoperative fluid therapy,
* occurrence of respiratory complications (assessment of the duration of mechanical ventilation and passive oxygen therapy),
* demand for painkillers in the postoperative period, after introducing the preemptive strategy,
* incidence of postoperative delirium,
* time to recovery of the normal bowel function (nausea, vomiting),
* possibility of early mobilisation on the first day after surgery,
* patient's satisfaction with treatment assessed on the basis of a survey carried out on the day before leaving the hospital.

Participant Groups

  • Implemented ERAS (Early Recovery After Surgery) elements

  • The control group will consist of patients treated during the study in accordance with the current standards used in the Department

Eligibility Criteria

Sex: All
Age Groups: Child / Adult / Older Adult
Healthy Volunteers: Yes

Inclusion Criteria:

* CABG/OPCAB (Coronary Artery Bypass Surgery/Off Pump Coronary Bypass Surgery).
* Left ventricular ejection fraction above 35% (EF ≥ 35%).
* The operation was performed in a planned mode.

Exclusion Criteria:

* Haematological diseases and the associated increased risk of bleeding in the early postoperative period. Patients taking anticoagulants until the day of surgery with the exception of aspirin.
* Neurological disorders, stroke with persistent symptoms, dementia.
* Chronic lung disease with hypoxia and the need for regular medication.
* Inability to move independently, disability preventing efficient rehabilitation, prolonged use of painkillers.
* Emergency surgery, reoperation.
* Return to the operating room regardless of the reason (resternotomy).
* Perioperative infarction with circulatory destabilization.

Primary Outcomes
  • Number of interventions for the ERAS protocol that are delivered to patient (numeric data e.g. 5 out of 10)

  • Total amount of days spent in hospital

Secondary Outcomes
  • Assessment of patient's emotional status according to Anxiety Likert Scale (consisted of five evenly spaced numbers each anchored to a level of anxiety: 1="not at all anxious," 2="a little anxious," 3="moderately anxious," 4="very anxious," 5="extremely anxious)

  • Time taken until patient extubated post operation (in hours)

  • Pain scores at 6hours, Numeric scale 0 (no pain) - 10 (severe pain)

  • To calculate the PONV Impact Scale score, add the numerical responses to questions 1 and 2. A PONV Impact Scale score of ≥5 defines clinically important PONV (Q1. Have you vomited: 0. No 1. Once 2. Twice 3. Three or more times Q2. Have you experienced a feeling of nausea :0. Not at all 1. Sometimes 2. Often or most of the time 3. All of the time)

  • Time until patient first drinks post extubation (in hours)

  • Time until patient first eats post extubation (in hours)

  • Hours elapsed to event

  • Delirium Screening according to Nursing Delirium Screening Scale, Each feature is scored on 0-2 based on severity, with 0=absent, 1=mild, and 2=severe. Positive Nu-DESC is score ≥2, maximum total score is 10

  • Rate measurement

  • First mobilisation with nurse/physiotherapist post-op (in hours)

Other Outcomes
  • This process resulted in the QoR-15 questionnaire ( Part A: How have you been feeling in the last 24 hours; 0-10 0-poor, 10 - excellent; rated areas: breath,food,feeling rested, sleep, hygiene,communicate, getting support, return to work, feeling comfortable, well-being; Part B Have you had any of following in the last 24h: modreate pain, severe pain, nause or vomiting, feeling worried, feeling sad; 10-0, 10 - none of the time, 0 - all of the time

More Details

NCT Number: NCT03956420
Other IDs: KNW/0022/KB1/26/18
Study URL: https://clinicaltrials.gov/study/NCT03956420
Last updated: Sep 29, 2023